Catalyst Biosciences Net Worth 2006-2021 | CBIO
Interactive chart of historical net worth (market cap) for Catalyst Biosciences (CBIO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Catalyst Biosciences net worth as of October 20, 2021 is $0.12B.
||Medical - Biomedical and Genetics
Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic which are in clinical different trail. Catalyst Biosciences, Inc., formerly known as Targacept, Inc., is based in South San Francisco, Calif.